Log in to save to my catalogue

Polyphosphazene-Based Nanocarriers for the Release of Camptothecin and Epirubicin

Polyphosphazene-Based Nanocarriers for the Release of Camptothecin and Epirubicin

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_351b34d8cea545e5ae2ae1960bc87af2

Polyphosphazene-Based Nanocarriers for the Release of Camptothecin and Epirubicin

About this item

Full title

Polyphosphazene-Based Nanocarriers for the Release of Camptothecin and Epirubicin

Publisher

Switzerland: MDPI AG

Journal title

Pharmaceutics, 2022-01, Vol.14 (1), p.169

Language

English

Formats

Publication information

Publisher

Switzerland: MDPI AG

More information

Scope and Contents

Contents

The design and study of efficient polymer-based drug delivery systems for the controlled release of anticancer drugs is one of the pillars of nanomedicine. The fight against metastatic and invasive cancers demands therapeutic candidates with increased and selective toxicity towards malignant cells, long-term activity and reduced side effects. In th...

Alternative Titles

Full title

Polyphosphazene-Based Nanocarriers for the Release of Camptothecin and Epirubicin

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_351b34d8cea545e5ae2ae1960bc87af2

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_351b34d8cea545e5ae2ae1960bc87af2

Other Identifiers

ISSN

1999-4923

E-ISSN

1999-4923

DOI

10.3390/pharmaceutics14010169

How to access this item